Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1935301

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1935301

Vocal Biomarkers Market, By Therapeutic Application, By End User, By Geography

PUBLISHED:
PAGES: 152 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Vocal Biomarkers Market is estimated to be valued at USD 3,716.8 Mn in 2026 and is expected to reach USD 10,168.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 15.5% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 3,716.8 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 15.50% 2033 Value Projection: USD 10,168.7 Mn

Voice can serve as a useful tool in identifying the presence or risk of conditions such as depression, Parkinson's disease, and coronary artery disease. Moreover, Research institutes and companies engaged in voice and speech technology are partnering to identify vocal biomarkers that can aid in accurate disease diagnosis. Vocal biomarkers technology could be an advanced innovation in the field of medical diagnostics, allowing for minimally-invasive diagnostic procedures to detect chronic conditions. For instance, Beyond Verbal, Inc., Cogito Corporation, and Sonde Health are developing a voice-based platform to diagnose mental and physical health.

Market Dynamics

The vocal biomarkers technology would transform the way mental and physical health is diagnosed and would transform the healthcare industry. This voice-based technology would allow early diagnosis and preventive treatments. This is expected to benefit hospitals, health clinics, and individuals to monitor health condition and take appropriate medical action.

Key players are focused on collaborations, in order to gain strong foothold in the market and enhance their product portfolio which is expected to drive the market growth. For instance, in June 2016, Sonde Health Inc., obtained technology license from the Massachusetts Institute of Technology Lincoln Laboratory for the latter's voice-based technology platform intended for monitoring and diagnosing various mental and physical conditions. Moreover, Beyond Verbal, Inc. collaborated with Mayo Clinic in 2016 to conduct studies and identify vocal biomarkers that could help in diagnosing mental and physical health.

Key features of the study

  • This report provides in-depth analysis of the global vocal biomarkers market and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period (2026 - 2033), considering 2025 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global vocal biomarkers market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Beyond Verbal, Inc., Sonde Health Inc., Sharecare, Inc., IBM Corporation, and Cogito Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics.
  • The global vocal biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the vocal biomarkers market

Market Segmentation

  • Therapeutic Application Insights (Revenue, USD Mn, 2026 - 2033)
    • Psychological Disorders
    • Respiratory Disorders
    • Cardiovascular Disorders
  • End User Insights (Revenue, USD Mn, 2026 - 2033)
    • Hospitals
    • Health Insurers
    • Academic & Research Institutions
    • Government Organizations
  • Regional Insights (Revenue, USD Mn, 2026 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Beyond Verbal, Inc.
    • Sonde Health Inc.
    • Sharecare, Inc.
    • IBM Corporation
    • Cogito Corporation
    • AudEERING
    • VoiceSense
    • Winterlight Labs
    • Ellipsis Health
    • Vocalis Health
Product Code: CMI101

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Therapeutic Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • PEST Analysis
    • PORTER's Five Forces Analysis
    • Market Opportunities
    • Regulatory Scenario
    • Key Developments
    • Industry Trend

4. Global Vocal Biomarkers Market, By Therapeutic Application, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Psychological Disorders
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Respiratory Disorders
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Cardiovascular Disorders
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

5. Global Vocal Biomarkers Market, By End User, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Health Insurers
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Academic & Research Institutions
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Government Organizations
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

6. Global Vocal Biomarkers Market, By Region, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
  • North America
    • Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Market Share Analysis, By Country/Region, 2026, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
    • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis (3x3 Matrix)
  • Company Profiles
    • Beyond Verbal, Inc.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Sonde Health Inc.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Sharecare, Inc.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • IBM Corporation
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Cogito Corporation
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • AudEERING
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • VoiceSense
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Winterlight Labs
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Ellipsis Health
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Vocalis Health
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates

8. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!